FDA Inspection 1263418 — Bangaru H., M.D.
The FDA completed an inspection of Bangaru H., M.D. on Feb 12, 2025 in Mysore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 12, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mysore (India)
Additional Details
Clinical BA/BE